Amikacin peak post extended interval dosing:MCnc:Pt:Ser/Plas:Qn:

Preferred Label : Amikacin peak post extended interval dosing:MCnc:Pt:Ser/Plas:Qn:;

LOINC status : ACTIVE;

LOINC display name : Amikacin peak post extended interval dosing [Mass/Vol];

LOINC long common name : Amikacin [Mass/volume] in Serum or Plasma --peak post extended interval dosing;

LOINC short name : Amikacin Pk EID SerPl-mCnc;

Détails

Origin ID

31097-9;

UMLS CUI

C1146782;

Has challenge
- Peak post aminoglycoside extended interval dosing [LOINC Challenge]
- TDM Peak [LOINC Challenge]
Has component
- Amikacin [LOINC component]
- Amikacin^peak [LOINC component]
- Amikacin^peak post extended interval dosing [LOINC component]
- post [LOINC component]
Has property
- Mass Concentration [LOINC Property]
Has system
- Plasma [LOINC System]
- Serum [LOINC System]
- Serum or Plasma [LOINC System]
Has time aspect
- Point in time (spot) [LOINC time aspect]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients